Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 4Sarcoma 3Dermatologic 3Breast 3Head & Neck 2Gastrointestinal 2Thoracic 1NET 1Lymphoid 1Gynecologic 1Endocrine 1CNS 1

Conditions

Thyroid Neoplasms 1Pheochromocytoma 1Neuroendocrine Tumors 1Neoplasm Metastasis 1Adrenal Gland Neoplasms 1

Interventions

Everolimus 7lutetium Lu 177 dotatate 3lanreotide 3Erlotinib Hydrochloride 3surufatinib 2gallium Ga 68 dotatate 2dactolisib 2Sunitinib 2Octreotide 2Magnetic Resonance Spectroscopy 2Filgrastim 2Capecitabine 2trifluridine tipiracil drug combination 1tislelizumab 1telotristat ethyl 1telotristat 1pertuzumab 1pembrolizumab 1pelcitoclax 1pegfilgrastim 1fosbretabulin 1folfirinox 1famitinib 1entinostat 1arginyllysine 1amino-acid, glucose, and electrolyte solution 1alectinib 1Temozolomide 1Surveys and Questionnaires 1Somatostatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Cryosurgery × NET × Clear all
NCT03986593 2023-07-05

Cryoablation of Bone Metastases From Endocrine Tumors

Instituto do Cancer do Estado de São Paulo

Phase NA Terminated
17 enrolled
EndocrineHead & NeckNET

Adrenal Gland Neoplasms, Neoplasm Metastasis, Pheochromocytoma, Thyroid Neoplasms, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡